Venture capital firm GGV Capital has led a RMB100 million (US$15.7 million) series B round in Shanghai-based artificial intelligence-powered medical data solutions provider Synyi.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?